Next-generation cancer therapies: translating experimental advances into clinical practice
Postgraduate Medical Journal · 20.05.2026 · 102 (1208) · 497-510
DOI: 10.1093/postmj/qgaf242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Postgraduate Medical Journal, online erschienen am 21.01.2026. Verfasst von Eftal Kale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, TOBB University of Economics and Technology, Söğütözü District, Söğütözü Avenue No. 43, Z-06/02, 06560 Ankara, Turkey. Hauptthemen laut MEDLINE: Neoplasms, Precision Medicine, Immunotherapy, Molecular Targeted Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Recent advancements in cancer therapy have led to the emergence of innovative approaches that offer new hope to patients. This review provides a comprehensive overview of the latest cutting-edge technologies and strategies in cancer treatment, including clinically approved therapies and experimental modalities in preclinical or early clinical development, with a focus on their potential to improve patient outcomes. We examined next-generation therapies, including personalized immunotherapies, targeted molecular treatments, gene editing approaches, and artificial intelligence-driven strategies. By evaluating the current landscape of these therapies, we highlighted their benefits, limitations, and future directions. The integration of these advanced modalities into clinical practice holds promise for enhancing their efficacy, reducing side effects, and ultimately transforming cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, TOBB University of Economics and Technology, Söğütözü District, Söğütözü Avenue No. 43, Z-06/02, 06560 Ankara, Turkey.
- Department of Medical Biology, Faculty of Medicine, TOBB University of Economics and Technology, Söğütözü District, Söğütözü Avenue No. 43, Z-06/02, 06560 Ankara, Turkey.
ORCID-Profile: Eftal Kale, Eren Guzes, Feyzanur Alatas, Parisa Sharafi
Zitieren
APA
Kale, E., Guzes, E., Alatas, F., & Sharafi, P. (2026). Next-generation cancer therapies: translating experimental advances into clinical practice. Postgraduate Medical Journal, 102(1208), 497-510. https://doi.org/10.1093/postmj/qgaf242
Vancouver
Kale E, Guzes E, Alatas F, Sharafi P. Next-generation cancer therapies: translating experimental advances into clinical practice. Postgraduate Medical Journal. 2026;102(1208):497-510. doi:10.1093/postmj/qgaf242
BibTeX
@article{Kale2026,
author = {Kale, Eftal and Guzes, Eren and Alatas, Feyzanur and Sharafi, Parisa},
title = {Next-generation cancer therapies: translating experimental advances into clinical practice},
journal = {Postgraduate Medical Journal},
year = {2026},
volume = {102},
number = {1208},
pages = {497--510},
doi = {10.1093/postmj/qgaf242}
}
EUVIMED